automated clinical management & Prior Authorization

Remove Delays in Cancer Treatment.
Save Lives. Lower Cost.


The problem is clear. Delayed cancer care compromises patient experience and promotes cancer stage progression.  Cancer stage progression reduces survival and increases the cost of health care.  

The solution is also clear. Preventing treatment delay prevents cancer stage progression, improves cancer survival, increases the value of healthcare, and enhances patient and provider experience.

XpediteMD is a shared digital health platform that unites patients, healthcare providers and payers around the common goals of increasing the efficiency, quality and value of cancer care. XpediteMD accomplishes these goals by eliminating treatment delays, by ensuring evidence-based, guideline-supported care, and by reducing the direct and indirect cost of healthcare.

Doctor With Record
Sub Title Icon

about us

Welcome To The Next Generation of Care Delivery

The strong correlation between cancer treatment delay, reduced survival, and higher healthcare cost has focused national attention on the importance of timely treatment of cancer. As a result, prompt “time to treatment” has been adopted as a quality measure by several national professional societies, advocacy groups, and accreditation organizations. Time to treatment is on the verge of being regulated by emerging federal and state legislation. Payers are already being penalized for delaying life-saving care.  Ironically, new “time to treatment” standards are being established despite the absence of proven, evidence-based solutions to ensure timely care delivery.  

Enter XpediteMD as a care delivery solution for a new generation. Created by physicians, researchers, and utilization management experts, XpediteMD is an evidence-based, clinical management and prior authorization solution that conveniently slots into clinical workflows and accomplishes what other solutions only aspire to do: reliably increase the efficiency, quality, and value of cancer care.  

By combining clinical decision support, novel patient and order tracker mechanisms, and automated prior authorization, the XpediteMD eliminates the gap between patient care decisions and approval of guideline-compliant care while also minimizing delays between the initiation, scheduling, completion, and resolution of medical orders. The end result is improved efficiency, value, and equity of cancer care while enhancing patient, provider, and payor experience.
  • Faster Care
  • Better Outcomes
  • Reduced Disparity
  • Greate Value
Book A Demo
Counter Icon

55%

Reduction in Time to Treatment
Counter Icon

100%

Guideline-Compliant Care
Counter Icon

0%

Denied Claims
Reduction in Cost of Care
Sub Title Icon

Cancer Types

Broad Platform Coverage

Service Icon

Breast Cancer

1.5 million women undergo breast biopsies each year in the U.S. for suspected breast cancer and over 210,000 are ultimately diagnosed.  Every 4-week delay in the work-up and treatment of breast cancer increases the relative risk of death by 8-28% and increases the cost of cancer care.  XpediteMD eliminates treatment delays that compromise breast cancer survival and drive up healthcare cost.
Service Icon

Colorectal Cancer

15 million men and women undergo colonoscopy each year in the U.S. to rule out colorectal cancer and over 210,000 are ultimately diagnosed.  Every 4-week delay in the work-up and treatment of colorectal cancer increases the relative risk of death by 6-13% and increases the cost of cancer care.  XpediteMD eliminates treatment delays that compromise colorectal cancer survival and drive up healthcare cost.
Service Icon

Bladder Cancer

Near a half million men and women in the U.S. undergo cystoscopy each year for suspected bladder cancer and over 80,000 of them are ultimately diagnosed with bladder cancer. Every 4-week delay in the work-up and treatment of bladder cancer increases the relative risk of death by 6-24%. XpediteMD eliminates treatment delays that compromise bladder cancer survival and drive up healthcare cost.
Service Icon

Lung Cancer

1 million men and women in the U.S. undergo biopsies each year to rule out lung cancer and nearly 230,000 of them are ultimately diagnosed with lung cancer.  For early stage lung cancer, every 1-week treatment delay increases the relative risk of lung cancer death by 4% and increases the cost of cancer care. XpediteMD eliminates treatment delays that compromise lung cancer survival and drive up healthcare cost.
Service Icon

Head and Neck Cancer

Each year, nearly 70,000 men and women in the U.S. are diagnosed with head and neck cancer.  Every 4-week delay in the work-up and treatment of head and neck cancer increases the relative risk of death by 6-9% and increases the cost of cancer care. XpediteMD eliminates treatment delays that compromise head and neck cancer survival and drive up healthcare cost.
Service Icon

Prostate Cancer

1 million men in the U.S. undergo prostate cancer biopsies to rule out prostate cancer and nearly 180,000 are ultimately diagnosed. Although delays in prostate cancer treatment have not been directly correlated with survival, failure to adhere to national treatment guidelines contributes to prostate cancer health disparities.  XpediteMD eliminates health disparity that compromises prostate cancer survival and drives up healthcare cost.
Sub Title Icon

get In Touch with us

Xpedite your treatment process today

Our team assists with planning, implementation, and continuous adjustments to ensure program success
Form User Icon
Form Email Icon
Form Phone Number
Form Phone Number
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sub Title Icon

BENEFITS OF CONSULTATION

Consult The Best Doctor
In The Department

Doctor are choosing from our diverse pool of health specialists. Discover better health & wellness by using our doctor ratings & reviews to make your choice.

SAY HELLO TO
DENTIST

Consult video icon
5:36mins

SAY HELLO TO
Surgeon

Consult video icon
7:12mins
Sub Title Icon

testimonials

What Our Clients and Patients Say

Sub Title Icon

our blog

Sub Title Icon

Latest Articles